Ireland· IE-PA-EU/1/15/1082/001
Galafold 123 mg hard capsules
A medicinal product containing migalastat hydrochloride, registered in Ireland by Amicus Therapeutics Europe Limited.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
The record
At a glance
HPRA (Ireland)- Active substance
- Migalastat hydrochloride
- Manufacturer
- Amicus Therapeutics Europe Limited
- Country
- Ireland (IE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/15/1082/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Migalastat hydrochloride in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumGalafold 123 mgAmicus Therapeutics Europe
- CanadaGALAFOLDAMICUS THERAPEUTICS CANADA INC.
- SwitzerlandGalafold
- CzechiaGALAFOLDAmicus Therapeutics Europe Limited, Dublin
- SpainGALAFOLD 123 MG CAPSULAS DURASAmicus Therapeutics Europe Limited
- FinlandGalafoldAmicus Therapeutics Europe Limited
- FranceGALAFOLD 123 mg, géluleAMICUS THERAPEUTICS EUROPE (IRLANDE)
- United KingdomGalafold 123mg capsulesAmicus Therapeutics UK Operations Ltd
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Galafold
- Liechtenstein · Galafold
- Norway · Galafold
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6e2000e5-0c1f-4cbd-bb31-7faa283907c9 GET /v1/drugs/6e2000e5-0c1f-4cbd-bb31-7faa283907c9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Capsule, hard",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": null,
"strength": null,
"pa_number": "EU/1/15/1082/001",
"substances": [
"Migalastat hydrochloride"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "26/05/2016",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about migalastat hydrochloride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.